Drugs to avoid or use with caution in myasthenia gravis
Avoid | |
D-penicillamine botulinum toxin type A interferon alfa |
– |
Use with caution | |
neuromuscular blocking drugs: |
Intravenous lidocaine and large doses of other local anaesthetics (even given subcutaneously) can potentiate the effect of neuromuscular blocking drugs. However, in general, local anaesthesia is safe in myasthenia gravis |
nondepolarising |
Avoid if possible, or use with extreme caution (cause highly variable potentiation of neuromuscular blockade) Avoid long-acting agents (eg pancuronium) Reduce doses, according to disease severity and concurrent use of anticholinesterase inhibitors Closely monitor neuromuscular function and consider a test dose |
depolarising |
Avoid if possible, due to variable response A loss of acetylcholine receptors in myasthenia gravis may confer a degree of resistance to depolarising drugs In contrast, cholinesterase inhibitors and vancomycin may potentiate the action of suxamethonium |
halogenated inhalation anaesthetics |
Myasthenic patients may be more sensitive to the relaxant effect of inhaled anaesthetics. Monitor neuromuscular function closely |
antibiotics: | |
aminoglycosides |
Use an alternative drug when possible. Tobramycin is probably the least toxic |
fluoroquinolones |
Use an alternative drug when possible |
macrolides |
Use an alternative drug when possible |
quinine |
Use an alternative drug when possible |
iodinated radiographic contrast media |
Use noncontrast imaging when possible and discuss with radiologist |
Note: NB1: Case reports suggest several other drugs (eg beta blockers [including eye drops], verapamil, statins, lincosamide antibiotics) exacerbate myasthenia gravis symptoms. Rather than avoiding these drugs completely, consider their harms versus benefits before deciding whether to use them.
|